Blog

Medspira Receives FDA 510K Clearance for mcompass Anorectal Manometry Device

Medspira Receives FDA 510K Clearance for mcompass Anorectal Manometry Device May 21, 2012 - Minneapolis - Medspira has received U.S. Food and Drug (FDA) 510K clearance for its innovative mcompass anorectal manometry device. Anorectal manometry testing evaluates pelvic floor function in patients with constipation or fecal incontinence.
Read More

Medspira Venture Funding

Venture Funding Medspira, an innovative medical device company, has received a $2,250,000 investment from a private venture group to build on the success of its flagship Breath Hold respiratory motion monitoring system and bring additional clinically-inspired medical technologies to market.
Read More

RSNA 2011 Breath Hold Introduction

RSNA Introduction Medspira debuts at RSNA 2011 enhanced Breath Hold, an easy-to-use standalone system for respiration monitoring across multiple imaging modalities, with special monitoring applications in radiation therapy (RT) for treatments involving the lungs and upper abdomen. An innovative proactive solution, Breath Hold enables patients to accurately self monitor their breathing patterns based on biofeedback…
Read More